@phdthesis{https://doi.org/10.17169/refubium-28671,<br/><span class="tab"></span>
  doi = {10.17169/REFUBIUM-28671},<br/><span class="tab"></span>
  url = {https://refubium.fu-berlin.de/handle/fub188/28922},<br/><span class="tab"></span>
  author = {Bell,<br/><span class="tab"></span> Roland},<br/><span class="tab"></span>
  keywords = {Streptococcus Pneumoniae,<br/><span class="tab"></span> Vaccines,<br/><span class="tab"></span> Innate Immune System,<br/><span class="tab"></span> Adaptive Immune System,<br/><span class="tab"></span> Rational Vaccine Design,<br/><span class="tab"></span> 600 Technik,<br/><span class="tab"></span> Medizin,<br/><span class="tab"></span> angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit},<br/><span class="tab"></span>
  title = {A semi-synthetic glycoconjugate vaccine for Streptococcus pneumoniae serotype 3 confers short-term protection against pneumonia in mice},<br/><span class="tab"></span>
  publisher = {Charité - Universitätsmedizin Berlin},<br/><span class="tab"></span>
  year = {2021},<br/><span class="tab"></span>
  copyright = {Creative Commons Attribution Non Commercial 4.0 International}
}